Search - tctmd.com

Displaying 241 - 259 of 259

Sort: Relevancy | Date

Presentation TCT 2012

Choice of Antiplatelet Therapies in ACS/STEMI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

US Perspective

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Randomized Trials vs. Observational Studies: Advantages and Pitfalls

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Contrast-Induced Nephrotoxicity

Presenter: Roxana Mehran

October 22, 2012

Presentation SCAI 2012

Left Main/Multivessel PCI v. CABG: Where Are They Today?

Presenter: Roxana Mehran

May 09, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation PCI Outcomes 2012

Case 3: A Patient with Recurrent Stent Thrombosis

Presenter: Roxana Mehran

March 23, 2012

Presentation CIT 2012

How to start and set up a Research Program? The Basic Tools

Presenter: Roxana Mehran

March 15, 2012

Presentation TCT 2012

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Presenter: Rudolf Jarai, Kurt Huber, Ke S. Xu, Bimmer Claessen, Georg Dangas, Roxana Mehran, Gregg Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Presenter: Sorin J. Brener, Ecaterina Cristea, Roxana Mehran, Ovidiu Dressler, Alexandra J. Lansky, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Ke Xu, Avery E. Clark, Rebecca Pinnelas, Bernhard Witzenbichler, Ran Kornowski, Giulio Gaugliumi, Eugenia Nikolsky, Bruce R. Brodie, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Liliana Grinfeld, Ke Xu, Martin Fahy, Eugenia Nikolsky, Rebecca Pinnelas, Avery E. Clark, Bruce R. Brodie, Martin Mockel, Bernard Witzenbichler, Ran Kornowski, Dariusz Dudek, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Presenter: John A. McPherson, Akiko Maehara, Giora Weisz, Gary S. Mintz, Ecaterina Cristea, Roxana Mehran, Michael Foster, Stefan Verheye, Leroy Rabbani, Ke Xu, Martin Fahy, Alexandra J. Lansky, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

$Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...$

Presentation TCT 2012

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Presenter: Shyam Poludasu, Usman Baber, Chabbra Sandeep, Jennifer Yu, Rebecca Pinnelas, Avery E. Clark, Roxana Mehran, George Dangas, Annapoorna S. Kini, Samin K. Sharma

January 03, 2012

Presentation TCT 2012

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Presenter: Eugenia Nikolsky, Bernard J. Gersh, Dangas D. George, Shing-Chiu Wong, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical and Economic Outcomes in Diabetic Women

Presenter: Erin M. Galbraith, Roxana Mehran, Chandan Devireddy, Henry A. Liberman, Steven V. Manoukian, Michele D. Voeltz

January 03, 2012

Presentation TCT 2012

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Presenter: Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David Cox, Martin Fahy, Ke Xu, Roxana Mehran, Gregg W. Stone

January 03, 2012

Advertisement

Choice of Antiplatelet Therapies in ACS/STEMI

US Perspective

Randomized Trials vs. Observational Studies: Advantages and Pitfalls

Contrast-Induced Nephrotoxicity

Left Main/Multivessel PCI v. CABG: Where Are They Today?

Oral Antiplatelet Agents in PCI and ACS

Case 3: A Patient with Recurrent Stent Thrombosis

How to start and set up a Research Program? The Basic Tools

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical and Economic Outcomes in Diabetic Women

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content